Results 41 to 50 of about 3,323,629 (269)

Combining Androgen Deprivation and Immunotherapy in Prostate Cancer Treatment: A Mechanistic Approach

open access: yesApplied Sciences, 2022
Due to its initial dependence on testosterone, prostate cancer patients are initially treated with androgen deprivation therapy, a form of chemical castration. However, in many cases, the cancer develops resistance to this treatment.
Johnna Barnaby, Harsh Vardhan Jain
doaj   +1 more source

Radiation therapy and androgen deprivation in the management of high risk prostate cancer

open access: yesInternational Brazilian Journal of Urology, 2011
The combined use of radiation therapy (RT) and androgen deprivation for patients with localized high-risk prostate cancer is commonly accepted as the standard treatment among uro-oncologists.
Alan Dal Pra   +2 more
doaj   +1 more source

Dual Compartmentalization of GSTA4 Suppresses Ferroptosis to Drive Antiandrogen Resistance in Prostate Cancer

open access: yesAdvanced Science, EarlyView.
The schematic diagram depicts a compartmentalized anti‐ferroptotic defense mechanism mediated by GSTA4. GSTA4 is upregulated and localizes to the cytoplasm in ENZR cells, where it detoxifies 4‐HNE via a non‐canonical GSH‐dependent pathway. Under oxidative stress, GSTA4 translocates to mitochondria, interacts with PGAM5, and blocks Drp1 Ser637 ...
Yong Luo   +17 more
wiley   +1 more source

Supplementary material for "Resistance exercise counteracts the impact of androgen deprivation therapy on muscle characteristics in cancer patients"

open access: yes, 2023
Table 1: Habitual dietary intake and physical activity level at baseline and following either 20 weeks of usual care (Control) or resistance exercise training (Exercise) in prostate cancer patients on androgen deprivation therapy.
Milou Beelen (15187664)   +9 more
core   +1 more source

Degrading GPX4 via Biomimetic Nanoparticle‐Mediated In Situ Synthesis of Deep‐Learning‐Designed Binder‐Degron Chimeras for Prostate Cancer Therapy

open access: yesAdvanced Science, EarlyView.
A deep‐learning‐designed binder is fused to a combinatorial degron to create a binder‐degron chimera (bdC) that recruits the CUL2‐RING ubiquitin ligase complex. Encapsulation in a prostate‐cancer‐targeted, CD47‐camouflaged nanocarrier enables tumor‐specific in situ bdC expression, triggering GPX4 degradation and ferroptosis, thereby establishing a ...
Si‐Han Zhang   +8 more
wiley   +1 more source

The role of radiotherapy in localised and locally advanced prostate cancer

open access: yesAsian Journal of Urology, 2019
For a patient suffering from non-metastatic prostate cancer, the individualized recommendation of radiotherapy has to be the fruit of a multidisciplinary approach in the context of a Tumor Board, to be explained carefully to the patient to obtain his ...
Michel Bolla   +3 more
doaj   +1 more source

Contemporary role of androgen deprivation therapy for prostate cancer [PDF]

open access: yes, 2012
Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most effective systemic palliative treatments known for solid tumors.
Pagliarulo, Vincenzo   +24 more
core   +1 more source

Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer

open access: yes, 2022
Androgen deprivation therapy (ADT) is a systemic therapy for advanced prostate cancer (PCa). Although most patients initially respond to ADT, almost all cancers eventually develop castration resistance.
Zihua Chen   +4 more
core   +1 more source

Decoding Biomolecular Phase Separation: From Physiological Roles to Pathological Mechanisms and Therapeutic Biomaterials Design

open access: yesAdvanced Science, EarlyView.
This review systematically elaborates on the mechanisms underlying physiological regulation and pathological dysregulation of biomolecular phase separation. It also summarizes advances in phase‑separation‑targeted therapeutic strategies and the design of functional biomaterials inspired by this process.
Jiawei Zhu   +5 more
wiley   +1 more source

Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation

open access: yesNeoplasia: An International Journal for Oncology Research, 2018
Current treatment strategies provide minimal results for patients with castration-resistant prostate cancer (CRPC). Attempts to target the androgen receptor have shown promise, but resistance ultimately develops, often due to androgen receptor ...
Nicholas E. Brown   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy